NEW YORK, Dec. 18 (Genome Web News) - Sequenom has licenced to Procter & Gamble Pharmaceuticals an undisclosed number of osteoporosis targets against which the drug company hopes to develop new therapeutics, the companies said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.
CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.
In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.
